Kósa Dóra

1.

Bácskay, I., Arany, P., Fehér, P., Józsa, L., Vasvári, G., Nemes, D., Pető, Á., Kósa, D., Haimhoffer, Á., Ujhelyi, Z., Sinka, D. Z.: Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: a Review.
Pharmaceutics. 17 (2), 1-19, (article identifier: 148), 2025.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmaceutical Science (2024)

2.

Kósa, D., Pető, Á., Bácskay, I.: Pharmaceutical aspects of conventional and recent developments for the treatment of metabolic diseases and disorders.
In: Pharmacological Targets in Metabolic Diseases. Ed.: by Marcos Roberto de Oliveira, Elsevier, London, 53-62, 2025. ISBN: 9780443273704

DEA

3.

Papp, B., Józsa, L., Pető, Á., Kósa, D., Ujhelyi, Z., Pallér, Á., Bácskay, I., Fehér, P.: CK2 inhibitor tartalmú alginát mikrogyöngyök formulálása és vizsgálata különböző segédanyagokkal.
egis. 3 (3), 18-30, 2024.

DEA

4.

Gavra, D. I., Kósa, D., Pető, Á., Józsa, L., Ujhelyi, Z., Fehér, P., Pallag, A., Ghitea, T. C., Frǎțilǎ, S., Jurca, T., Bácskay, I.: Exploring the Correlation between the PASI and DLQI Scores in Psoriasis Treatment with Topical Ointments Containing Rosa x damascena Mill. Extract.
Pharmaceuticals (Basel). 17 (8), 1092-1105, 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

5.

Balogh, B. N., Pető, Á., Haimhoffer, Á., Sinka, D. Z., Kósa, D., Fehér, P., Ujhelyi, Z., Argenziano, M., Cavalli, R., Bácskay, I.: Formulation and Evaluation of Different Nanogels of Tapinarof for Treatment of Psoriasis.
Gels. 10 (11), 1-18, (article identifier: 675), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Bioengineering

Q2 Biomaterials

Q1 Organic Chemistry

Q1 Polymers and Plastics

6.

Bácskay, I., Papp, B., Pártos, P., Budai, I., Pető, Á., Fehér, P., Ujhelyi, Z., Kósa, D.: Formulation and Evaluation of Insulin-Loaded Sodium-Alginate Microparticles for Oral Administration.
Pharmaceutics. 16 (1), 1-16, (article identifier: 46), 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmaceutical Science

7.

Bácskay, I., Hosszú, Z., Budai, I., Ujhelyi, Z., Fehér, P., Kósa, D., Haimhoffer, Á., Pető, Á.: Formulation and Evaluation of Transdermal Patches Containing BGP-15.
Pharmaceutics. 16 (1), 1-18, (article identifier: 36), 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmaceutical Science

8.

Alsheikh, R., Haimhoffer, Á., Nemes, D., Ujhelyi, Z., Fehér, P., Józsa, L., Vasvári, G., Pető, Á., Kósa, D., Nagy, L., Horváth, L., Balázs, B., Bácskay, I.: Formulation of Thermo-Sensitive In Situ Gels Loaded with Dual Spectrum Antibiotics of Azithromycin and Ofloxacin.
Polymers. 16 (21), 1-20, (article identifier: 2954), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Chemistry (miscellaneous)

Q1 Polymers and Plastics

9.

To Quoc, T., Bíró, K., Pető, Á., Kósa, D., Haimhoffer, Á., Lekli, I., Pallér, Á., Bak, I., Gyöngyösi, A., Fehér, P., Bácskay, I., Ujhelyi, Z.: The Role of Amphiphilic Compounds in Nasal Nanoparticles.
AAPS PharmSciTech. 25 (8), 1-14, (article identifier: 269), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Agronomy and Crop Science

Q2 Aquatic Science

Q2 Drug Discovery

Q2 Ecology

Q2 Ecology, Evolution, Behavior and Systematics

Q2 Medicine (miscellaneous)

Q2 Pharmaceutical Science

10.

To Quoc, T., Bíró, K., Pető, Á., Kósa, D., Sinka, D. Z., Lekli, I., Kiss-Szikszai, A., Budai, I., Béres, M., Vecsernyés, M., Fehér, P., Bácskay, I., Ujhelyi, Z.: Development and Evaluation of an FDM Printed Nasal Device for CPZ Solid Nanoparticles.
Molecules. 28 (11), 1-15, (article identifier: 4406), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Analytical Chemistry

Q1 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

11.

Papp, B., Borgne, M. L., Perret, F., Marminon, C., Józsa, L., Pető, Á., Kósa, D., Nagy, L., Kéki, S., Ujhelyi, Z., Pallér, Á., Budai, I., Bácskay, I., Fehér, P.: Formulation and Investigation of CK2 Inhibitor-Loaded Alginate Microbeads with Different Excipients.
Pharmaceutics. 15 (12), 1-18, (article identifier: 2701), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmaceutical Science

12.

Józsa, L., Nemes, D., Pető, Á., Kósa, D., Révész, R., Bácskay, I., Haimhoffer, Á., Vasvári, G.: Recent Options and Techniques to Assess Improved Bioavailability: in Vitro and Ex Vivo Methods.
Pharmaceutics. 15 (4), 1-25, (article identifier: 1146), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmaceutical Science

13.

Pető, Á., Kósa, D., Szilvássy, Z., Fehér, P., Ujhelyi, Z., Kovács, G., Német, I., Pócsi, I., Bácskay, I.: Scientific and Pharmaceutical Aspects of Christensenella minuta, a Promising Next-Generation Probiotic.
Fermentation. 9 (8), 1-11, (article identifier: 767), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q2 Food Science

Q2 Plant Science

14.

Sinka, D. Z., Doma, E., Szendi, N., Páll, J., Kósa, D., Pető, Á., Fehér, P., Ujhelyi, Z., Fenyvesi, F., Váradi, J., Vecsernyés, M., Szűcs, Z., Gonda, S., Cziáky, Z., Kiss-Szikszai, A., Vasas, G., Bácskay, I.: Formulation, Characterization and Permeability Studies of Fenugreek (Trigonella foenum-graecum) Containing Self-Emulsifying Drug Delivery System (SEDDS).
Molecules. 27 (9), 2846-, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

15.

Kósa, D., Pető, Á., Fenyvesi, F., Váradi, J., Vecsernyés, M., Budai, I., Németh, J., Fehér, P., Bácskay, I., Ujhelyi, Z.: Oral Bioavailability Enhancement of Melanin Concentrating Hormone, Development and In Vitro Pharmaceutical Assessment of Novel Delivery Systems.
Pharmaceutics. 14 (1), 1-15, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmaceutical Science

16.

Bácskay, I., Ujhelyi, Z., Pető, Á., Kósa, D., Józsa, L., Vasas, G., Zsuga, J., Fehér, P.: Prebiotikum tartalmú kapszulák formulálása és vizsgálata.
egis. 1 (1), 2-8, 2022.

doi DEA

17.

Pető, Á., Kósa, D., Haimhoffer, Á., Nemes, D., Fehér, P., Ujhelyi, Z., Vecsernyés, M., Váradi, J., Fenyvesi, F., Frum, A., Gligor, F. G., Vicaș, L. G., Marian, E., Jurca, T., Pallag, A., Mureşan, M., Tóth, Z., Bácskay, I.: Topical Dosage Formulation of Lyophilized Philadelphus coronarius L. Leaf and Flower: antimicrobial, Antioxidant and Anti-Inflammatory Assessment of the Plant.
Molecules. 27 (9), 1-18, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

18.

Ranjous, Y., Kósa, D., Ujhelyi, Z., Regdon, G., Nagy, K. A., Szenti, I., Kónya, Z., Bácskay, I., Sovány, T.: Evaluation of the permeability and in vitro cytotoxicity of functionalized titanate nanotubes on Caco-2 cell line.
Acta Pharm Hung. 91 (1), 31-39, 2021.

doi DEA

19.

Józsa, L., Bácskay, I., Ujhelyi, Z., Pető, Á., Kósa, D., Arany, P., Nemes, D., Sinka, D. Z., Vecsernyés, M., Fehér, P.: Formulation and Investigation of Gels Containing Spirulina Powder.
Acta Pharm Hung. 91 (3-4), 245-246, 2021.

doi DEA

20.

Kósa, D., Pető, Á., Fenyvesi, F., Váradi, J., Vecsernyés, M., Gonda, S., Vasas, G., Fehér, P., Bácskay, I., Ujhelyi, Z.: Formulation of Novel Liquid Crystal (LC) Formulations with Skin-Permeation-Enhancing Abilities of Plantago lanceolata (PL) Extract and Their Assessment on HaCaT Cells.
Molecules. 26 (4), 1-15, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

21.